Perfil
Kelly Devine Deck is currently the Chief Financial Officer at Inhibrx, Inc. and a Trustee at The Fleet Science Center.
Previously, she worked as the Executive Director-Finance at Apricus Biosciences, Inc. from 2013 to 2018.
Cargos activos de Kelly Deck
| Empresas | Cargo | Inicio |
|---|---|---|
| INHIBRX, INC. | Director of Finance/CFO | - |
| Fleet Science Center | Director/Board Member | - |
Antiguos cargos conocidos de Kelly Deck.
| Empresas | Cargo | Fin |
|---|---|---|
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/01/2018 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INHIBRX, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
| Fleet Science Center |
- Bolsa de valores
- Insiders
- Kelly Deck
